Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipsen

Market Cap 12.9B 14.86B 11.89B 11.14B 20.81B 1,423B 21.25B 142B 54.91B 686B 55.79B 54.59B 2,385B P/E Ratio 2026 *
14.5x
P/E Ratio 2027 * 14.2x
Enterprise Value 11.54B 13.29B 10.63B 9.96B 18.62B 1,273B 19B 127B 49.11B 614B 49.9B 48.83B 2,133B EV / Sales 2026 *
2.71x
EV / Sales 2027 * 2.39x
Free-Float
40.65%
Yield 2026 *
0.91%
Yield 2027 * 0.95%
1 day+1.29%
1 week+3.83%
Current month+0.32%
1 month-5.59%
6 months+29.30%
Current year+32.02%
1 week 152.7
Extreme 152.7
159.2
1 month 148.7
Extreme 148.7
167.4
Current year 116
Extreme 116
173.5
1 year 100.2
Extreme 100.2
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2020
Chief Executive Officer 57 31/12/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 29/08/2005
Chairman 68 21/11/2010
Director/Board Member 69 31/05/2012
Date Insider Type Main position Quantity % Market Cap.
05-31Fiscal year

Chief Executive Officer

-26,583 0.0317%
05-26Sell

Chief Executive Officer

-1,000 0.0012%
02-24Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%+3.83%+49.48%+41.66% 14.71B
+2.16%+3.17%+43.57%+160.71% 1,013B
-0.07%+4.45%+53.50%+49.05% 574B
-0.08%-0.08%+17.37%+63.20% 397B
-0.37%+4.97%+21.24%+15.95% 324B
+0.85%+2.79%+24.89%+15.93% 280B
+2.10%+7.06%+24.57%+34.79% 273B
+4.84%+2.45%+21.33%+62.89% 182B
-0.19%+3.96%-45.64%-48.23% 194B
+3.61%-2.56%+15.16%+61.66% 151B
Average +1.59%+2.63%+22.55%+45.76% 340.34B
Weighted average by Cap. +1.42%+3.98%+29.49%+72.65%

Financials

2026 *2027 *
Net sales 4.25B 4.9B 3.92B 3.67B 6.86B 469B 7.01B 46.77B 18.11B 226B 18.4B 18B 787B 4.41B 5.08B 4.07B 3.81B 7.12B 487B 7.27B 48.51B 18.78B 235B 19.08B 18.67B 816B
Net income 923M 1.06B 851M 797M 1.49B 102B 1.52B 10.15B 3.93B 49.09B 3.99B 3.91B 171B 916M 1.06B 844M 791M 1.48B 101B 1.51B 10.07B 3.9B 48.69B 3.96B 3.88B 169B
Net Debt -1.36B -1.57B -1.26B -1.18B -2.2B -150B -2.24B -14.98B -5.8B -72.43B -5.89B -5.76B -252B -2.37B -2.73B -2.19B -2.05B -3.83B -262B -3.91B -26.08B -10.1B -126B -10.26B -10.04B -439B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
11/06/26 157.10 +1.29% 143,949
10/06/26 155.10 -1.77% 129,360
09/06/26 157.90 +0.06% 113,067
08/06/26 157.80 0.00% 118,590
05/06/26 157.80 +2.20% 122,859
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
157.10EUR
Average target price
159.25EUR
Spread / Average Target
+1.37%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!